Stock listing
Newbury Pharmaceuticals Ab
Selected listing: P52 · FWB · EUR · DE
Newbury Pharmaceuticals Ab (Frankfurt:P52), Health Technology. Latest release Sep 28, 2026: Newbury Pharmaceuticals secures exclusive rights to a 40-product…
- Ticker
- Frankfurt:P52
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Frankfurt
- Currency
- EUR
Latest news from Newbury Pharmaceuticals Ab
Newbury Pharmaceuticals secures exclusive rights to a 40-product hospital portfolio in Iraq
September 28, 2026
Newbury Pharmaceuticals : accelerates its neuroscience ambitions with a new partnership for Guanfacine tablets
August 17, 2026
Newbury Pharmaceuticals Secures Generic Approval for Tofacitinib Newbury
July 13, 2026
Newbury Pharmaceuticals Secures Generic Approval for Dalbavancin Newbury
July 10, 2026
Newbury Pharmaceuticals Secures Generic Approval for Palbociclib Newbury
April 17, 2026
Research Newbury Pharmaceuticals Ab
Newbury Pharmaceuticals Ab company profile
View the public company page for Newbury Pharmaceuticals Ab on 6ix.
Newbury Pharmaceuticals Ab news
Read company news and market updates connected to Newbury Pharmaceuticals Ab.
Newbury Pharmaceuticals Ab investor events
Find investor webinars, events, and replay context for Newbury Pharmaceuticals Ab.